Stopcocks & Stopcock Manifolds Market is Set for Lucrative Growth During 2021–2028 – MRS Updates – KSU ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Some of the major factors driving the growth of the Drug Delivery Equipment market are the rise in the geriatric population, as well as collaborations and partnerships, to facilitate drug development. Additionally, the increase in healthcare expenditure has significantly contributed to market growth. An increase in the number of pipeline drugs and huge growth potential from emerging economies are more likely to provide lucrative opportunities for the market to expand.
The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Global Disposable Auto-injectors Market Set to Make Rapid Strides in 2020-2027 texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Credit: Serenno device
Israeli developer of medical devices for patient monitoring, Serenno Medical has announced that global producer of medical devices, Elcam Medical has invested in the company and will also manufacture Sentinel, Serenno s urine output and intra-abdominal pressure digital monitoring device for the detection of acute kidney injury (AKI).
Elcam Medical join existing investors Alon Medtech and serial medical device inventor, entrepreneur and investor, Dr Shimon Eckhouse.
WHY IT MATTERS
The partnership combines Serenno’s kidney device with Elcam’s manufacturing experience to enable the use of Sentinel in a variety of hospital environments.
Kidney function assessment allows the early detection of AKI, a common condition in hospitalised patients that increases risk of mortality during and after hospitalisation.
Elcam Medical Joins Serenno Medical as Strategic Investor and Manufacturer of its Automatic Monitoring of Kidney Function Device
USA - English
News provided by
Share this article
YOKNEAM, Israel, Jan. 20, 2021 /PRNewswire/
Serenno Medical, developer of medical devices for patient monitoring in a hospital setting, announced today that
Elcam Medical, a leading producer of medical devices, has invested $1.5 million in the Company and will also manufacture Sentinel™, Serenno s urine output and intra-abdominal pressure digital monitoring device for the detection of acute kidney injury (AKI). Elcam Medical join existing investors
Alon Medtech and serial medical device inventor, entrepreneur and investor, Dr. Shimon Eckhouse.